The ultimate in cancer chemoprevention: cancer vaccines
- PMID: 20332303
- DOI: 10.1158/1940-6207.CAPR-10-0043
The ultimate in cancer chemoprevention: cancer vaccines
Abstract
This perspective on Beatty et al. (beginning on page 438 in this issue of the journal) discusses the role of the immune system as nature's ultimate chemoprevention agent. A successful immune response to vaccination results in immunologic memory. In the case of a successful cancer-related response, antigen-specific T cells will be poised to destroy an aberrantly expressed protein even if the host is not exposed until years after the end of immunizations. After the abnormal cell is eradicated, T cells will lie in wait for the next exposure. The ability to develop effective cancer vaccines for prevention is fast becoming a reality as immunogenic aberrant proteins that drive malignant transformation are identified.
(c) 2010 AACR.
Comment on
-
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.Cancer Prev Res (Phila). 2010 Apr;3(4):438-46. doi: 10.1158/1940-6207.CAPR-09-0194. Epub 2010 Mar 23. Cancer Prev Res (Phila). 2010. PMID: 20332301 Free PMC article.
Similar articles
-
Cancer vaccines: between the idea and the reality.Nat Rev Immunol. 2003 Aug;3(8):630-41. doi: 10.1038/nri1150. Nat Rev Immunol. 2003. PMID: 12974478 Review.
-
Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.Haematologica. 2002 Sep;87(9):989-1001. Haematologica. 2002. PMID: 12217812 Review.
-
A possible "universal" cancer vaccine that might cause an immune response against emerging cancer cells that originate from any tissue.Med Hypotheses. 2008;70(2):381-3. doi: 10.1016/j.mehy.2007.04.040. Epub 2007 Jul 12. Med Hypotheses. 2008. PMID: 17629418
-
Immune responses to human tumors: development of tumor vaccines.Anticancer Res. 2003 May-Jun;23(3A):1969-96. Anticancer Res. 2003. PMID: 12894571 Review.
-
Cancer vaccines: an update with special focus on ganglioside antigens.Oncol Rep. 2002 Mar-Apr;9(2):267-76. Oncol Rep. 2002. PMID: 11836591 Review.
Cited by
-
Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.J Immunol. 2011 Aug 15;187(4):1788-96. doi: 10.4049/jimmunol.1101138. Epub 2011 Jul 11. J Immunol. 2011. PMID: 21746967 Free PMC article.
-
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Cancer Immunol Immunother. 2011 Jul;60(7):999-1007. doi: 10.1007/s00262-011-1005-7. Epub 2011 Apr 5. Cancer Immunol Immunother. 2011. PMID: 21465317 Free PMC article.
-
Personalized immune-interception of cancer and the battle of two adaptive systems--when is the time right?Cancer Prev Res (Phila). 2013 Mar;6(3):173-6. doi: 10.1158/1940-6207.CAPR-13-0011. Epub 2013 Jan 22. Cancer Prev Res (Phila). 2013. PMID: 23341571 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources